Psyence Biomedical PBM
NASDAQ PBM
$4.12 -0.40 (-8.85%)
As of: Oct 22, 2026 · 3:59 PM EDT

Psyence Biomedical (PBM) Ending Cash Balance (2023 - 2026)

Updated

Analysis

Psyence Biomedical (PBM) Ending Cash Balance (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Ending Cash Balance (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 16.91 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 6.57 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 6.89 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 7.62 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 4.88 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 3.18 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 1.03 Bn
10 Psyence Biomedical 2.33 Mn -20.33 Mn - 7.44 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 7.44 Mn
Sep 30, 2023 605,480.00
Mar 31, 2023 1.33 Mn
API Access

Psyence Biomedical Ending Cash Balance API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=PBM&period=max&api_key=YOUR_API_KEY